Skip to main content

Table 6 Distribution of histology and stage in second primary lung cancer (SPLC) patients with history of an initial primary lung HGNEC

From: Risk of second primary malignancy in adults with pulmonary high-grade neuroendocrine carcinoma (HGNEC)

 

SPLC Histology

Small cell

Other or unknown

Total

Squamous cell

Adenocarcinoma

HGNEC Histology

N

Row(%)

N

Row(%)

N

Row(%)

N

Row(%)

 

 SCLC

206

38%

141

26%

81

15%

114

21%

542

 LCNEC

20

23%

34

40%

16

19%

15

18%

85

Total

226

36%

175

28%

97

15%

129

21%

627

 

SPLC Stage

    

Localized

Regional

Distant

Unstaged

Total

HGNEC Stage

N

Row(%)

N

Row(%)

N

Row(%)

N

Row(%)

 

 Localized

71

51%

32

23%

34

24%

3

2%

140

 Regional

130

44%

71

24%

86

29%

9

3%

296

 Distant

68

41%

40

24%

52

31%

7

4%

167

 Unstaged

12

50%

4

17%

7

29%

1

4%

24

Total

281

45%

147

23%

179

29%

20

3%

627